Gary Hattersley's most recent trade in Nuvation Bio Inc - Ordinary Shares - Class A was a trade of 300,000 Class A Common Stock done at an average price of $7.2 . Disclosure was reported to the exchange on Nov. 20, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Nuvation Bio Inc (Class A) | Gary Hattersley | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 7.23 per share. | 20 Nov 2025 | 300,000 | 0 | - | 7.2 | 2,168,100 | Class A Common Stock |
| Nuvation Bio Inc (Class A) | Gary Hattersley | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.94 per share. | 20 Nov 2025 | 300,000 | 300,000 | - | 1.9 | 582,000 | Class A Common Stock |
| Nuvation Bio Inc (Class A) | Gary Hattersley | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 300,000 | 200,000 | - | - | Stock Option (Right to Buy) | |
| Nuvation Bio Inc (Class A) | Gary Hattersley | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 7.23 per share. | 20 Nov 2025 | 69,051 | 0 | - | 7.2 | 499,032 | Class A Common Stock |
| Nuvation Bio Inc (Class A) | Gary Hattersley | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.74 per share. | 20 Nov 2025 | 69,051 | 69,051 | - | 1.7 | 120,149 | Class A Common Stock |
| Nuvation Bio Inc (Class A) | Gary Hattersley | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 69,051 | 229,884 | - | - | Stock Option (Right to Buy) | |
| Nuvation Bio Inc (Class A) | Gary Hattersley | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Oct 2025 | 100,000 | 298,935 | - | - | Stock Option (Right to Buy) | |
| Nuvation Bio Inc (Class A) | Gary Hattersley | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 5.02 per share. | 27 Oct 2025 | 100,000 | 0 | - | 5.0 | 502,460 | Class A Common Stock |
| Nuvation Bio Inc (Class A) | Gary Hattersley | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.74 per share. | 27 Oct 2025 | 100,000 | 100,000 | - | 1.7 | 174,000 | Class A Common Stock |
| Nuvation Bio Inc (Class A) | Gary Hattersley | CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 500,000 | 500,000 | - | - | Stock Option (Right to Buy) | |
| Nuvation Bio Inc (Class A) | Gary Hattersley | CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Feb 2024 | 500,000 | 500,000 | - | - | Stock Option (Right to Buy) | |
| Nuvation Bio Inc (Class A) | Gary Hattersley | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 500,000 | 500,000 | - | - | Stock Option (Right to Buy) |